- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03248700
Vitamin A Kinetics and Mathematical Modeling in American Women
October 29, 2019 updated by: University of Wisconsin, Madison
Women were given a vitamin A tracer, and blood was sampled to determine individual and group vitamin A kinetics.
Data were subsequently modeled using compartmental analysis to determine effects of study length on model outcomes.
Study Overview
Detailed Description
This is a longitudinal study in which American women were given an oral, stable isotope tracer of vitamin A, and blood was sampled in a staggered, serial design to determine individual and group vitamin A kinetics.
Data were subsequently modeled using compartmental analysis, and study truncation analysis was performed on data to investigate the factor of study duration on resulting vitamin A kinetic models and outputs related to vitamin A metabolism.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53706
- Department of Nutritional Sciences, University of Wisconsin-Madison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- BMI (18.5 - 24.9 kg/m2)
Exclusion Criteria:
- Smoker
- Pregnant
- Trying to become pregnant
- Lactating
- Weight loss > 4.5 kg during the past 3 months.
- Actively trying to lose weight
- Inability to refrain from drinking alcohol when requested
- Amenorrhea
- Acute or chronic illness including hepatitis
- Current or previous history of anorexia or bulimia
- Concurrent participation in other studies
- Family member already enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vitamin A tracer
A stable isotope tracer of vitamin A was given orally.
|
A stable isotope tracer of vitamin A was given orally.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total traced vitamin A mass
Time Frame: Baseline through 152 days
|
Total amount of endogenous vitamin A determined by mathematical model, (µmol).
|
Baseline through 152 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compartmental model complexity
Time Frame: Baseline through 152 days
|
Required number of compartments in mathematical model needed to adequately fit data.
|
Baseline through 152 days
|
Compartmental model fractional transfer coefficients
Time Frame: Baseline through 152 days
|
Model parameters adjusted to fit analytical data.
Represents the fractional transfer from one compartment to another in the model, (pools/d, represented as L(i,j), the fraction of compartment J transferred to compartment I per day).
|
Baseline through 152 days
|
Serum vitamin A half-life
Time Frame: Baseline through 152 days
|
Half-life of vitamin A in serum, (d).
|
Baseline through 152 days
|
Vitamin A disposal rate
Time Frame: Baseline through 152 days
|
Daily loss or utilization of vitamin A, (µmol/d).
|
Baseline through 152 days
|
Vitamin A equilibration time and partitioning
Time Frame: Baseline through 152 days
|
Time taken for vitamin A to equilibrate with body stores, (d).
|
Baseline through 152 days
|
Vitamin A tracer partitioning
Time Frame: Baseline through 152 days
|
Body partitioning of tracer between serum and extravascular compartment(s), relative to total tracee mass.
Calculated as a ratio of tracer-to-tracee ratio (TTR) in serum and extravascular stores, (TTR serum / TTR stores).
|
Baseline through 152 days
|
Vitamin A dietary intake
Time Frame: Baseline
|
Vitamin A dietary intake by food frequency questionnaire, (µg retinol activity equivalents/d).
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sherry A Tanumihardjo, PhD, University of Wisconsin, Madison
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2008
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
August 8, 2017
First Submitted That Met QC Criteria
August 11, 2017
First Posted (Actual)
August 14, 2017
Study Record Updates
Last Update Posted (Actual)
October 31, 2019
Last Update Submitted That Met QC Criteria
October 29, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2008-0020
- A074600 (Other Identifier: UW Madison)
- AG&LSC/NUTRITIONAL SCI/NUTRITI (Other Identifier: UW, Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Kinetics
-
Cheikh Anta Diop University, SenegalInternational Atomic Energy AgencyNot yet recruiting
-
Institute of Nutrition of Central America and PanamaBill and Melinda Gates Foundation; Newcastle University; International Atomic...Completed
-
Prince of Songkla UniversityUnknown
-
University of California, DavisHelen Keller InternationalCompleted
-
Tufts UniversityNutricia Research Fundation; National University of Science and Technology,...Completed
-
University of California, DavisBill and Melinda Gates Foundation; Penn State University; Newcastle University; Helen Keller International and other collaboratorsCompletedVitamin A StatusPhilippines
-
NIZO Food ResearchFrieslandCampinaCompleted
-
Maastricht University Medical CenterBioActorRecruiting
-
IVI MadridTerminated
-
University Hospital, Clermont-FerrandService Biologie de la reproduction-CECOSUnknownSpermatic Parameters | Embryonic KineticsFrance
Clinical Trials on Vitamin A tracer
-
Texas A&M UniversityNot yet recruiting
-
Institute for Neurodegenerative DisordersMolecular NeuroImagingTerminatedAlzheimer DiseaseUnited States
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States
-
Idorsia Pharmaceuticals Ltd.Completed
-
Soon Chun Hyang UniversityCompletedCholecystitis | Pancreatitis | CholangitisKorea, Republic of
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of UtahNational Cancer Institute (NCI); MultiFunctional Imaging LLCRecruiting
-
University College, LondonUniversity of Oxford; Cancer Research UKActive, not recruitingGliomaUnited Kingdom
-
Fujian Medical UniversityRecruiting
-
Ohio State University Comprehensive Cancer CenterRecruitingAllogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States